Event Calendar

Our diverse portfolio of events are organised into three thematic brands.
You can filter to search within the brands and region of most interest, and search by topic keyword.

30 September - 01 October 2025
London, UK
Europe’s flagship event for biomarker innovation returns, advancing drug discovery, development, clinical trials, and precision medicine.
30 September 2025
Precision Medicine’s definitive benchmark for excellence
October 02 - 03, 2025
San Diego, CA
Driving the Development of Novel and Alternative Therapies Through Safe, Effective and Precise Formulation and Delivery Solutions
October 02 - 03, 2025
San Diego, CA
Uniting North American biopharma decision-makers to innovate at speed, equipping them with the critical intelligence & partners they require to make informed pipeline decisions in early-stage R&D
October 02 - 03, 2025
San Diego, CA
Uniting North American biopharma leaders in biologics and ADC discovery & development to accelerate innovation, providing the critical insights and partnerships needed for smarter early-stage R&D pipeline decisions
27 - 28 October 2025
San Francisco, CA
Bringing together 1000+ leaders to drive innovation in precision medicine through Biomarkers, Digital Pathology & AI, and Spatial Biology.
11 - 12 November 2025
London, UK
Connecting Leaders From Every Stage of the Value Chain to Drive Advanced Therapy Development & Novel Biologics Processing
13 - 14 November 2025
London, UK
Uniting multi-omics leaders to accelerate omics research across therapeutic areas through NGS, Multi-Omics, NextGen Omics Data, and Liquid Biopsies.
21 January 2026
Online, GMT (UTC+0)
Explore the latest advances in novel target identification, validation, and exploration for immuno-oncology
17 February 2026
Online, GMT (UTC+0)
This showcase highlights the latest tools and technologies transforming multi-omic data integration, analysis pipelines, & computational workflows
19 February 2026
Online, GMT (UTC+0)
Explore the latest advances in peptide computational discovery, featuring AI-driven peptide design and innovative synthesis techniques
12 March 2026
Online, GMT (UTC+0)
Explore the latest advances in AI-driven technologies and novel formulation strategies transforming drug development
24 - 25 March 2026
London, UK
From groundbreaking discoveries to real-world applications: Bringing the next generation of biomedicines from concept to market
March 31 – April 01, 2026
Boston, MA
From Novel Technologies to Clinical Applications: Driving the Next Generation of Multi-Omics Research
09 April 2026
Online, BST (UTC+1)
This showcase highlights cutting-edge technologies driving innovation in spatial biology
14 April 2026
Online, BST (UTC+1)
Dive into cutting-edge innovations in ADC bioconjugation chemistry and tackle the toughest challenges head-on
06 May 2026
Online, BST (UTC+1)
Unlock the full potential of laboratory automation to revolutionise your R&D workflows
20 May 2026
Online, BST (UTC+1)
Explore cutting-edge advancements in computational antibody discovery platforms, featuring real-world case studies on AI/ML in antibody engineering
15 - 16 June 2026
Berlin, Germany
Championing innovation within formulation and delivery by bringing together thought leaders who can advance complex, next generation drug formats to market
15 - 16 June 2026
Berlin, Germany
Pushing traditional boundaries in pharmaceutical science by accelerating the discovery of novel therapeutics
30 June 2026
Online, BST (UTC+1)
This showcase delves into the latest technologies shaping precision oncology, from genomics profiling and immuno-oncology biomarkers to circulating tumour cell (CTC) analysis and liquid biopsy innovations etc.
17 September 2026
Online, BST (UTC+1)
Uncover the latest in cell line development, where CRISPR, AI, and automation are driving faster, more precise engineering
22 September 2026
Online, BST (UTC+1)
Unlock the future of drug discovery with innovative screening techniques that enhance efficiency, precision, and throughput
26 November 2026
Online, GMT (UTC+0)
This showcase spotlights the evolving landscape of proteomics in biomarker discovery and clinical development